Skip to main content
. 2013 May 1;18(5):568–578. doi: 10.1634/theoncologist.2012-0427

Table 1.

Median age in important multimodality randomized trials on head and neck cancer

graphic file with name onc00513-1321-t01.jpg

aMean age.

bTotal of 25 patients who were >70 years old (5%).

Abbreviations: DMFS, distant metastases-free survival; ECOG, Eastern Cooperative Oncology Group; EFS, event-free survival; FU, fluorouracil; LC, local control; LRPFS, local recurrence progression-free survival; M, Methotrexate; OS, overall survival; PFS, progression-free survival; RFS, recurrence-free survival; RT, radiation therapy; TTP, time to progression; VBMF, vincristine, bleomycine, methotrexate, and fluorouracil.